JPRN-UMIN000014539Recruiting未知
Examination about the influence that DPP-4 inhibitor gives for a left ventricle function in acute myocardial infarction - Examination about the influence that DPP-4 inhibitor gives for a left ventricle function in acute myocardial infarction
Center for Cardiovascular Interventions,Chiba University Hospital0 sites38 target enrollmentStarted: July 11, 2014Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 38
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 80years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1) Severe renal disease or dialysis patient 2) Insulin-dependent patient (CPR index <0.8) 3) Patient of type I diabetes mellitus 4) The patient who uses DPP-4 inhibitor, GLP-1 preparation in either from three months ago before hospitalization to the hospitalization direct front 5) Patient having a serious liver disease 6) Patient with the possibility of the pregnancy or the pregnancy, the patient whom I am nursing 7) Patient having a side effect for DPP-4 inhibitor, antiplatelet and the anticoagulant 8) The patient who develops lower limbs confinement-related arteriosclerosis having severe lower limbs ischemia 9) Patient having heart failure of NYHAIV 10) In addition, the patient who judged an examination responsibility (allotment) doctor to be inappropriate as a subject
Investigators
Similar Trials
Recruiting
Not Applicable
Investigation of the impact of DPP-4 inhibition on serum brain natriuretic peptide level of diabetic patients with congestive heart failure.JPRN-UMIN000015685Mitsui Memorial Hospital50
Not yet recruiting
Not Applicable
The inhibitory effects of the DPP-4 inhibitor for progression of diabetic nephropathy, in the patients with type 2 diabetes in Japan.The CKD patients with type 2 diabetesJPRN-UMIN000011101Saitama Medical Center, Saitama Medical University50
Active, not recruiting
Not Applicable
Quantification of the DPP-4 inhibition-mediated enhancement of the activity of the entero-insular axisDiabetes Type 2MedDRA version: 9.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusEUCTR2008-001663-11-DEDiabeteszentrum Bad Lauterberg
Recruiting
Not Applicable
Multicenter study of inhibitory effect of DPP-4 inhibitor (and/ ARB) on hepatic fibrosis in patients with diabetes and liver dysfunctioJPRN-UMIN000008068Third department of Internal Medicine, Nara Medical University100
Completed
Not Applicable
A randomized and comparative study of DPP4 inhibitors versus SGLT2 inhibitors using cotinuous glucose monitoring (CGM)JPRN-UMIN000015087Yokohama City University Medical Center20